AbCellera Biologics Inc. (ABCL) insider trading.
In Q3 2026, insiders at AbCellera Biologics Inc. reported 5 non-derivative transactions on 8 Forms 3, 4 and 5: 4 open-market purchases worth $1.5M and 0 sales.
- Transactions
- 5
- Purchases (P)
- 4
- Sales (S)
- 0
- Net shares, P minus S
- 147,200
- Insiders
- 3
- Last filed
- 2026-08-24
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Hayden Michael R | Director | 3 | 2 | 0 |
| Montalbano John S. | Director | 1 | 1 | 0 |
| Booth Andrew | Officer · Chief Financial Officer | 1 | 1 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-24 | Hayden Michael R | P (A) | 53,613 | $10.64 | 1,373,397 | Form 4 |
| 2026-08-18 | Montalbano John S. | P (A) | 10,000 | $11.03 | 251,000 | Form 4 |
| 2026-08-14 | Booth Andrew | P (A) | 37,200 | $10.32 | 482,800 | Form 4 |
| 2026-08-12 | Hayden Michael R | P (A) | 46,387 | $10.37 | 1,319,784 | Form 4 |
| 2026-08-11 | Hayden Michael R | G (D) | 50,000 | $0 | 1,273,397 | Form 4 |
Transaction codes in this quarter
Get ABCL insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1703057&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ABCL company page · AbCellera Biologics Inc. on SEC.gov
Questions
Are insiders buying or selling AbCellera Biologics Inc. (ABCL)?
In Q3 2026, insiders at AbCellera Biologics Inc. reported 5 non-derivative transactions on 8 Forms 3, 4 and 5: 4 open-market purchases worth $1.5M and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these AbCellera Biologics Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/abcl.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.